Last 5 Days Trading Activity
|Date||Open Price||Close Price||High||Low||Volume|
Last 5 Days Short Activity
|Date||Short Volume||Total Volume||Short Percentage||Short Indicator|
* Short Mode
About HH Biotechnology Holdings Company (OTC: HHBT)
Great China International Holdings Inc is a comprehensive real estate developer with over years experience with real estate operation in China. It is now one of the largest non state owned real estate developers in Northeast China. The company s core business is premium residential and commercial development and management. It currently owns and manages the PresidentBuilding, a twin tower commercial building completed in April , with more than leased by Fortune companies. At present, the occupancy rate of PresidentBuilding has consectively ranked No. among all the rental properties. The company s prior developments included MarylandBuilding, QiyunNewVillage, PeacockGarden, University Campus of Shenyang Teacher s University, and ChenglongGarden, most located in Shenyang. These projects have become a real showcase of success of Great China International Holdings.
- Sheng Jiang / CEO
- Lirong Wang / CFO
- Shuang Li / Secretary
- Sasaki Koji / VP, Mkt.
- Liang Zou / VP, Ops.
- Kunpeng Yu / VP, Prod. Dev.
Current Share Structure
- Market Cap: $14,059,966 - 03/09/2018
- Issue and Outstanding: 14,059,966 - 03/31/2015
Daily Technical Chart for (OTC: HHBT)
Stay tuned for daily updates and more on (OTC: HHBT)
More to come on (OTC: HHBT)
Do your DD and if you choose, be ready to go!
The Research: All source information contained in this email is from the public sources mentioned below.
Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in HHBT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of HHBT and does not buy, sell, or trade any shares of HHBT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/